Bromfenac is a nonsteroidal anti-inflammatory drug (NSAID) for ophthalmic use. Ophthalmic NSAIDs are becoming a cornerstone for the management of ocular pain and inflammation. Their well-characterized anti-inflammatory activity, analgesic property, and established safety record have also made NSAIDs an important tool for optimizing surgical outcomes. Non-ophthalmic formulations of bromfenac were withdrawn in the US in 1998 due to cases of severe liver toxicity.[L43942,T239]
Synonyms
Bromfenaco
Bromfenacum
2-amino-3-(4-bromobenzoyl)benzeneacetic acid
Bromfenac
Bromfenac sodium
[2-Amino-3-(4-bromo-benzoyl)-phenyl]-acetic acid
Brand Names
Bromsite 0.075%
Bromfenac Sodium
Bromfenac Ophthalmic Solution, 0.07%
Strenza Plus
Apo-bromfenac
Bromfenac Ophthalmic Solution
Bromfenac
Pred-Gati-Brom
Bromfenac Ophthalmic Solution 0.09%
Auro-bromfenac
Xibrom
Pred-Brom
Bromfenac 0.075%
Pred Phos-Gati-Brom
Bromday
Prolensa
Yellox
Pred Phos - Brom
Bromfenac Ophthalmic Solution, 0.09%
Eugia-bromfenac
Indication
For the treatment of postoperative inflammation in patients who have undergone cataract extraction.
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682